These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15028606)

  • 1. In vivo effects of the I(2)-alkylating agent BU99006 on the immunodensity of imidazoline receptor proteins in the mouse brain.
    Garcia-Sevilla JA; Ferrer-Alcon M
    Ann N Y Acad Sci; 2003 Dec; 1009():323-31. PubMed ID: 15028606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of I
    Keller B; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
    Escribá PV; Ozaita A; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain.
    Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2002 Jul; 43(1):75-83. PubMed ID: 12213261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
    Olmos G; Alemany R; Boronat MA; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo estimation of imidazoline(2) binding site turnover.
    Paterson LM; Robinson ES; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
    Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of the imidazoline I(2) receptor ligand BU99006 in rats.
    Qiu Y; Thorn DA; Zhang Y; He X; Li JX
    Behav Pharmacol; 2014 Apr; 25(2):130-6. PubMed ID: 24518265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
    Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
    Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between imidazoline(2) sites and monoamine oxidase.
    Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an I(2) binding protein from rabbit brain.
    Kimura A; Tyacke RJ; Minchin MC; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():364-6. PubMed ID: 15028613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic imidazoline drug treatment increases the immunoreactivity of glial fibrillary acidic protein in rat brain. LSL 60101 as a novel and selective ligand for I2-imidazoline receptors.
    García-Sevilla JA; Alemany R; Olmos G; Menargues A; Obach R
    Ann N Y Acad Sci; 1995 Jul; 763():486-9. PubMed ID: 7677361
    [No Abstract]   [Full Text] [Related]  

  • 19. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2016 Sep; 30(9):875-86. PubMed ID: 27302941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.